Goitres Influence on Voice Function - The Impact of Surgery
SOLOIST
The Impact of Surgical Treatment of Benign Non-toxic Goiter on the Voice Function
1 other identifier
observational
60
1 country
1
Brief Summary
The aim of the study is to investigate the influence benign non-toxic goitre and the surgical treatment hereof on the voice function before and 6 months following surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2014
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2014
CompletedFirst Submitted
Initial submission to the registry
January 19, 2015
CompletedFirst Posted
Study publicly available on registry
June 11, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2018
CompletedNovember 8, 2016
November 1, 2016
3.9 years
January 19, 2015
November 7, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of patients with changed frequency range in voice function following thyroidectomy
Change in frequency range (Hz) of the Voice Range Profiler Phonetogram from baseline to 6 months after surgery.
6 months
Interventions
Regular thyroidectomy or hemithyroidectomy through Kocher's skin incision
Eligibility Criteria
All patients undergoing hemi- or total thyroidectomy at Odense University Hospital for benign symptomatic non-toxic goiter
You may qualify if:
- Patients undergoing hemi- or total thyroidectomy for benign non-toxic goiter with pressure symptoms
- The patients must be able to understand, write and read Danish
You may not qualify if:
- Previous surgery to the neck
- Diabetes or any neuromuscular disorders.
- Present or previous head and neck malignancy, including malignancy found in the surgical thyroid specimen or suspicion hereof.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Southern Denmarklead
- Odense University Hospitalcollaborator
Study Sites (1)
Odense University Hospital
Odense, 5000, Denmark
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Christian Godballe, Professor
University of Southern Denmark
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
January 19, 2015
First Posted
June 11, 2015
Study Start
November 1, 2014
Primary Completion
October 1, 2018
Study Completion
October 1, 2018
Last Updated
November 8, 2016
Record last verified: 2016-11